SCHEMBL25663156

SCHEMBL25663156

c1ccc2c(c1)sc1c(-c3ccc4cc(N(c5ccc(-c6ccc7ccncc7n6)cc5)c5ccc(-c6ccc7ccncc7n6)cc5)ccc4c3)ncnc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.37
▸ MINK1 Q8N4C8 1/20 0.37
▸ TNIK Q9UKE5 1/20 0.37
▸ LIMK1 P53667 7/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ HTR2C P28335 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ MAPK9 P45984 1/20 0.32
▸ MAPK10 P53779 1/20 0.32
▸ EGFR P00533 4/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ AR P10275 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663155 0.93 LIMK1 (0.35) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663157 0.89 LIMK1 (0.35) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663149 0.88 LIMK1 (0.40) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663150 0.87 LIMK1 (0.39) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663151 0.87 LIMK1 (0.35) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663153 0.85 NPC1 (0.38) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663488 0.85 LIMK1 (0.36) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663154 0.84 LIMK1 (0.36) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663489 0.83 LIMK1 (0.35) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663158 0.82 LIMK1 (0.37) LIMK1CDK5CDK5R1HTR2CHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 MAP4K4 3501/4885MINK1 3414/4885TNIK 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback